AM vs FRO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong profitability metrics like an 81.29% gross margin and 22.52% ROE, the company faces significant risks including a high 91.84% dividend payout ratio, elevated debt/equity of 1.46, and deteriorating earnings momentum. Insider selling, weak recent earnings beats (1 of last 4), and a technical trend score of 10/100 further signal caution. Although the stock trades near analyst target ($18.75 vs $18.93), it is overvalued relative to the Graham Number of $9.77, suggesting limited margin of safety for defensive investors.
Frontline plc presents a dichotomy between explosive growth and deteriorating execution. While the Piotroski F-Score of 4/9 indicates stable financial health, the company has failed to beat earnings estimates in the last four consecutive quarters, with an average surprise of -21.01%. The stock is trading significantly above its Graham Number ($20.77), suggesting a premium valuation that is not fully supported by its PEG ratio of 5.58. Despite strong operating margins and a healthy dividend, the technical trend is severely bearish (10/100), indicating a potential correction following a massive 1-year run-up.
Compare Another Pair
AM vs FRO: Head-to-Head Comparison
This page compares Antero Midstream Corporation (AM) and Frontline plc (FRO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.